107 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34893239 | Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy. | 2022 Feb 1 | 1 |
2 | 34985285 | Asparaginyl Endopeptidase-Mediated Protein C-Terminal Hydrazinolysis for the Synthesis of Bioconjugates. | 2022 Jan 19 | 1 |
3 | 34998092 | Targeting immunoliposomes to EGFR-positive glioblastoma. | 2022 Feb | 8 |
4 | 35167278 | EGFR Ligand Clustering on E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells. | 2022 Mar 16 | 1 |
5 | 35214137 | Photosensitive EGFR-Targeted Nanocarriers for Combined Photodynamic and Local Chemotherapy. | 2022 Feb 13 | 3 |
6 | 33111200 | Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects. | 2021 Jan | 1 |
7 | 33115283 | Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. | 2021 Mar | 1 |
8 | 33509300 | Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells. | 2021 Jan 28 | 3 |
9 | 33691834 | Preparation of Epidermal Growth Factor-Modified Targeted Doxorubicin Nanoliposomes and Therapy of Liver Cancer. | 2021 Sep 1 | 3 |
10 | 33814909 | EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. | 2021 | 7 |
11 | 34023418 | GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling. | 2021 Aug 28 | 1 |
12 | 34096285 | pH-Controlled Protein Orthogonal Ligation Using Asparaginyl Peptide Ligases. | 2021 Jun 16 | 1 |
13 | 34119884 | Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling. | 2021 Aug | 3 |
14 | 34298600 | Ultrasound-Mediated Cavitation Enhances EGFR-Targeting PLGA-PEG Nano-Micelle Delivery for Triple-Negative Breast Cancer Treatment. | 2021 Jul 6 | 3 |
15 | 34600360 | Capsule-like molecular imprinted polymer nanoparticles for targeted and chemophotothermal synergistic cancer therapy. | 2021 Dec | 2 |
16 | 34830320 | Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling. | 2021 Nov 18 | 1 |
17 | 31883395 | Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP-1 and HER2 expression and converted MCF7 breast cancer subtype. | 2020 May | 1 |
18 | 32866592 | Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug. | 2020 Dec 10 | 2 |
19 | 33022466 | Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling. | 2020 Dec | 1 |
20 | 30589193 | Selective Delivery of Doxorubicin to EGFR+ Cancer Cells by Cetuximab-DNA Conjugates. | 2019 Apr 15 | 4 |
21 | 30677497 | Sortagged anti-EGFR immunoliposomes exhibit increased cytotoxicity on target cells. | 2019 Mar | 1 |
22 | 31188543 | LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. | 2019 Oct | 1 |
23 | 31298380 | Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway. | 2019 Jun | 2 |
24 | 31299626 | Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy. | 2019 Oct | 6 |
25 | 31356633 | Effective treatment of cancer metastasis using a dual-ligand nanoparticle. | 2019 | 1 |
26 | 31534505 | Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. | 2019 | 2 |
27 | 31545462 | Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin. | 2019 Nov | 5 |
28 | 31704984 | Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells. | 2019 Nov 8 | 1 |
29 | 29570299 | GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment. | 2018 Sep 4 | 2 |
30 | 29855103 | Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe3 O4 Nanocapsules (BPQDs@ss-Fe3 O4 @C) with Low Premature Release Could Enable Imaging-Guided Cancer Combination Therapy. | 2018 Sep 3 | 7 |
31 | 29969563 | Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor. | 2018 Aug 8 | 2 |
32 | 30240496 | Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma. | 2018 Nov 12 | 1 |
33 | 27902463 | Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. | 2017 Jan 3 | 1 |
34 | 28229963 | Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway. | 2017 Mar | 1 |
35 | 28435266 | EGFR-targeted delivery of DOX-loaded Fe3O4@ polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy. | 2017 | 8 |
36 | 28482611 | Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy. | 2017 Jul 1 | 1 |
37 | 28593948 | Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy. | 2017 Jun 8 | 2 |
38 | 28688985 | Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy. | 2017 Sep 1 | 1 |
39 | 28776259 | Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling. | 2017 Dec | 5 |
40 | 29030307 | EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. | 2017 Dec | 4 |
41 | 29077410 | Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. | 2017 Dec 4 | 4 |
42 | 26176268 | Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery. | 2016 | 1 |
43 | 26505786 | Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. | 2016 Jan 11 | 1 |
44 | 26945977 | Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. | 2016 May 10 | 5 |
45 | 27050167 | Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. | 2016 | 1 |
46 | 27191929 | Sendai viroplexes for epidermal growth factor receptor-directed delivery of interleukin-12 and salmosin genes to cancer cells. | 2016 Jul | 1 |
47 | 27420618 | [Implication of integrin alpha5beta1 signal pathways in proliferation and apoptosis of MCF-7/Dox human breast carcinoma cells]. | 2016 Mar | 2 |
48 | 24798787 | Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. | 2015 Jan 1 | 1 |
49 | 25553823 | Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. | 2015 Feb 28 | 2 |
50 | 25662498 | Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes. | 2015 Mar | 14 |